![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 04 October 2021
Sec. Ethnopharmacology
Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.774792
This article is part of the Research Topic The Role of Natural Products in Chronic Inflammation View all 25 articles
This article is a correction to:
Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
A Corrigendum on
Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
by Huang, D., Wang, X., Zhu, Y., Gong, J., Liang, J., Song, Y., Zhang, Y., Liu, L., and Wei, C. (2021). Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:658,998. doi:10.3389/fphar.2021.658998
In the original article, there was a mistake in Table 1 as published. BZBS is a post-marketing drug, and there is an error in the components of BZBS and ratio amounts in application (Li et al., 2021). The corrected Table 1 appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: atherosclerosis, bazi bushen capsule, lipid profile, inflammation, GPER1 antagonist, apoptosis
Citation: Huang D, Wang X, Zhu Y, Gong J, Liang J, Song Y, Zhang Y, Liu L and Wei C (2021) Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:774792. doi: 10.3389/fphar.2021.774792
Received: 13 September 2021; Accepted: 17 September 2021;
Published: 04 October 2021.
Edited and reviewed by:
Hongzhi Du, Hubei University of Chinese Medicine, ChinaCopyright © 2021 Huang, Wang, Zhu, Gong, Liang, Song, Zhang, Liu and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Linsheng Liu, bGluc2hlbmdfbGl1QDEyNi5jb20=; Cong Wei, d2VpY29uZ0B5aWxpbmcuY24=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.